C. Grandclément

发表

Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance.

G. Salles, P. Rohrlich, F. Garnache-Ottou, 2010, Blood.

Degradation of organic micropollutants using a hybrid bioreactor

C. Grandclément, 2017 .

Neuropilin-2 Expression Promotes TGF-β1-Mediated Epithelial to Mesenchymal Transition in Colorectal Cancer Cells

M. Klagsbrun, J. Pallandre, J. Rémy-Martin, 2011, PloS one.

Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells

M. Delorenzi, C. Soneson, P. Romero, 2016, EBioMedicine.

Neuropilins: A New Target for Cancer Therapy

C. Grandclément, C. Borg, 2011, Cancers.

Activation by SLAM Family Receptors Contributes to NK Cell Mediated “Missing-Self” Recognition

C. Grandclément, G. Leclercq, A. Veillette, 2016, PloS one.

The Transcription Factor Tcf1 Contributes to Normal NK Cell Development and Function by Limiting the Expression of Granzymes.

M. Delorenzi, C. Grandclément, P. Angelino, 2017, Cell reports.

Opposing Mcl-1, the GALIG proapoptotic gene is upregulated as neutrophils die and underexpressed in Acute Myeloid Leukemia cells.

Axel Aurouet, Eric Deconinck, L. Mollet, 2013, Molecular immunology.

From the conventional biological wastewater treatment to hybrid processes, the evaluation of organic micropollutant removal: A review.

C. Grandclément, N. Roche, P. Doumenq, 2017, Water research.

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

G. Coukos, C. Akdis, S. Minucci, 2017, Nature Communications.

Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells.

X. Pivot, J. Pallandre, J. Rémy-Martin, 2011, Cancer research.

Microenvironment and Immunology Novel Role for STAT 3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells

X. Pivot, J. Rémy-Martin, C. Grandclément, 2011 .

Implication de la neuropiline-2 dans la Transition-Epithélio- Mésenchymateuse

C. Grandclément, 2011 .

Adaptations of Natural Killer Cells to Self-MHC Class I

Werner Held, C. Grandclément, E. Alari-Pahissa, 2014, Front. Immunol..

NK Cells Respond to Haptens by the Activation of Calcium Permeable Plasma Membrane Channels

C. Grandclément, H. Vogel, H. Pick, 2016, PloS one.

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

G. Coukos, C. Akdis, S. Minucci, 2017, Nature Communications.

ISB 1442, a First-in-Class CD38 and CD47 Bispecific Antibody Innate Cell Modulator for the Treatment of Relapsed Refractory Multiple Myeloma

G. Gudi, M. Panagopoulou, C. Grandclément, 2021, Blood.

Biological Removal and Fate Assessment of Diclofenac Using Bacillus subtilis and Brevibacillus laterosporus Strains and Ecotoxicological Effects of Diclofenac and 4′-Hydroxy-diclofenac

I. Laffont-Schwob, C. Grandclément, N. Roche, 2020, Journal of Chemistry.

Neuropilins: A New Target for Cancer Therapy

C. Grandclément, C. Borg, 2011, Cancers.

Neuropilin-2 and epithelial to mesenchymal transition in colorectal cancer cells.

M. Klagsbrun, X. Pivot, C. Grandclément, 2010 .

Inhibitory receptor-mediated regulation of natural killer cells.

C. Grandclément, W. Held, Beena Jeevan-Raj, 2014, Critical reviews in immunology.